CVE-2014-5370

Public Exploit

Description

Directory traversal vulnerability in the CFChart servlet (com.naryx.tagfusion.cfm.cfchartServlet) in New Atlanta BlueDragon before 7.1.1.18527 allows remote attackers to read or possibly delete arbitrary files via a .. (dot dot) in the QUERY_STRING to cfchart.cfchart.

Category

7.5
CVSS
Severity: High
CVSS 2.0 •
EPSS 8.82% Top 10%
Third-Party Advisory packetstormsecurity.com Third-Party Advisory seclists.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://packetstormsecurity.com/files/131504/BlueDragon-CFChart-Servlet-7.1.1.17759-Directory-Traversal.html third party advisory exploit
http://seclists.org/fulldisclosure/2015/Apr/49 third party advisory mailing list
https://www.portcullis-security.com/security-research-and-downloads/security-advisories/cve-2014-5370/ exploit
https://www.exploit-db.com/exploits/36815/ exploit
http://www.osvdb.org/119527 vdb entry broken link

Frequently Asked Questions

What is the severity of CVE-2014-5370?
CVE-2014-5370 has been scored as a high severity vulnerability.
How to fix CVE-2014-5370?
To fix CVE-2014-5370, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-5370 being actively exploited in the wild?
It is possible that CVE-2014-5370 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~9% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.